aspirin has been researched along with piplartine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; He, X; Liu, T; Song, H; Wu, S; Xie, J; Zhang, Y; Zhao, X; Zhao, Z; Zheng, X | 1 |
| Huang, W; Li, J; Liu, H; Wang, J; Wang, Y; Xie, D; Zhang, Y; Zhu, P; Zuo, J | 1 |
| Himmel, LE; Jyotsana, N; King, MR; Yu, F; Zhang, Z | 1 |
1 review(s) available for aspirin and piplartine
| Article | Year |
|---|---|
Research progress in the biological activities of 3,4,5-trimethoxycinnamic acid (TMCA) derivatives.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiviral Agents; Central Nervous System Agents; Cinnamates; Hematologic Agents; Molecular Structure | 2019 |
2 other study(ies) available for aspirin and piplartine
| Article | Year |
|---|---|
Design, Synthesis and Pharmacological Evaluation of Novel Piperlongumine derivatives as Potential Antiplatelet Aggregation Candidate.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aspirin; Blood Platelets; Dioxolanes; Drug Evaluation, Preclinical; Humans; Piperidones; Platelet Aggregation; Platelet Aggregation Inhibitors | 2016 |
Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection.
Topics: Animals; Apoptosis; Aspirin; Cell Line, Tumor; Cell Proliferation; Curcumin; Dioxolanes; E-Selectin; Female; Humans; Leukocytes; Liposomes; Mammary Glands, Animal; Mice; Neoplasm Metastasis; Neoplasms, Experimental; TNF-Related Apoptosis-Inducing Ligand; Triple Negative Breast Neoplasms | 2019 |